Has Theodore Fellenbaum, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,056 in general payments to Theodore Fellenbaum, MD across 372 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Theodore Fellenbaum, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Theodore Fellenbaum, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Theodore Fellenbaum, MD

Obstetrics & Gynecology · Flint, MINPI 1366457848

Payments from drug & device makers

$7,056in general payments, 2019–2025

Across 372 payments — averaging $18.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Medtronic$1K
Mayne Pharma Commercial LLC$633
Myovant Sciences Inc.$502
Pfizer$398
Sumitomo Pharma America, Inc.$315
plus $3K from 40 others

What the payments were for

Travel & lodging$1,04115%
Food & beverage$5,88083%
Education$1092%
Gifts$260%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	64	$1,199
Medtronic	11	$1,185
Mayne Pharma Commercial LLC	51	$633
Myovant Sciences Inc.	35	$502
Pfizer	22	$398
Sumitomo Pharma America, Inc.	20	$315
Ascend Therapeutics US, LLC	54	$213
Hologic Sales And Service, LLC	10	$211
Coopersurgical, Inc.	7	$193
Aspira Women's Health Inc	5	$164
Therapeuticsmd, Inc.	10	$159
Astellas Pharma US Inc	8	$136
Myriad Women's Health, Inc.	1	$125
Exact Sciences	5	$124
Dysis Medical, Inc.	4	$124
Daiichi Sankyo Inc.	6	$114
Lilly USA, LLC	2	$96
Covidien LP	1	$94
Boston Scientific	4	$78
Exeltis, USA Inc.	4	$71
Bayer	4	$69
Evofem Biosciences, Inc.	3	$64
Johnson & Johnson	2	$58
Channel Medsystems, Inc.	1	$54
Lupin Inc.	3	$51
Novo Nordisk	3	$50
AMAG Pharmaceuticals, Inc.	3	$47
Medicem Inc.	2	$46
Zyla Life Sciences, Inc.	3	$43
Currax Pharmaceuticals LLC	3	$41
BD	2	$41
Shield Therapeutics Inc	2	$40
Vertical Pharmaceuticals, LLC	2	$36
Millicent US Inc	2	$36
Gynesonics, Inc.	1	$33
Organon	2	$31
Integra Lifesciences Corporation	1	$28
Vertex	1	$24
Smith+Nephew	1	$22
Coloplast	1	$21
Scynexis, Inc.	1	$19
KCI USA, Inc.	1	$18
Pacira Pharmaceuticals Incorporated	1	$16
Duchesnay USA Incorporated	1	$12
Mylan Pharmaceuticals Inc.	1	$12
Merck	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,056 in reported general payments places this provider in the 90th percentile of 1,474 obstetrics & gynecology providers in Michigan.

See all obstetrics & gynecology providers in Michigan →

Medicare billing

Part B allowed, 2024

$35,443

Medicare patients

106

Services billed

382

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Estradiol	47	$3,197
Clindamycin Phosphate	25	$1,864
Estradiol (Twice Weekly)Estradiol	21	$1,827
Betamethasone Dipropionate	30	$1,040
Clobetasol Propionate	33	$894
ValacyclovirValacyclovir Hcl	14	$814
ProgesteroneProgesterone, Micronized	16	$555
Terconazole	14	$401
Mupirocin	22	$391
Mometasone Furoate	24	$321
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip	22	$270
Ondansetron OdtOndansetron	20	$230
Triamcinolone Acetonide	41	$224
Fluconazole	39	$214
Pregabalin	11	$111

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Flint

Haider MahdiDetroit$3.4M
Andrew WagnerMidland$2M
Jason BellAnn Arbor$548K
Jacquelyn RobinsonSaginaw$539K
Jouhaina MalehDearborn$524K
Awoniyi AwonugaSouthfield$445K
Rabbie HannaDetroit$421K
David EisensteinDetroit$296K
Duane HeilbronnSaginaw$234K
Donna HrozencikCanton$196K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →